Sponsored by:

Nuclear Medicine: Page 399

Syncor expects 10-Q filing delay
By AuntMinnie.com staff writers
Radiopharmaceutical provider Syncor International said it expects to file a notification of late filing on Form 12b-25 with the Securities and Exchange Commission.
November 12, 2002
Cytogen returns to Nasdaq compliance
By AuntMinnie.com staff writers
Biopharmaceutical developer Cytogen said that it has been notified by the Nasdaq Stock Market that it has regained compliance with the Nasdaq’s listing standard for minimum bid price.
November 11, 2002
Immunomedics net loss widens in Q1
By AuntMinnie.com staff writers
Immunomedics reported 2003 fiscal first-quarter revenues of $3.2 million, down slightly compared to last year's numbers.
November 11, 2002
CMS to maintain PET payment rates
By Kate Madden Yee
PET proponents are rejoicing at the news that the Centers for Medicare and Medicaid Services (CMS) will retain 2002 outpatient reimbursement rates for FDG-PET procedures next year. CMS had been proposing a 42% cut in the rate for oncology PET procedures and a 9% cut in cardiac PET payments for its 2003 outpatient payment schedule.
November 7, 2002
Toshiba names director of MRI and nuclear business unit
By AuntMinnie.com staff writers
Toshiba America Medical Systems has picked Dane Peshe as the director of its MRI and nuclear medicine business unit, responsible for developing marketing plans in these segments for the Tustin, CA-based vendor.
November 7, 2002
Stress test with SPECT remains main modality for assessing myocardial viability
Thanks to its ease of use and familiarity, SPECT is likely to remain the imaging modality of choice for myocardial viability assessment, even as other technologies emerge, according to a panel of experts at the 2002 American Society of Nuclear Cardiologists meeting in Baltimore.
November 7, 2002
Digirad tallies record Q3 sales
By AuntMinnie.com staff writers
Solid-state gamma camera developer Digirad recorded revenue of $11 million in the third quarter (end-September 30), up 39% compared to $7.9 million in the third quarter of 2001.
November 6, 2002
Cardinal uncovers questionable Syncor payments
By AuntMinnie.com staff writers
Healthcare giant Cardinal Health has uncovered evidence of "questionable payments" at Syncor International, the Woodland Hills, CA-based radiopharmaceutical company that Cardinal has proposed to acquire.
November 6, 2002
Brophy joins CTI as vice president and counsel
By AuntMinnie.com staff writers
PET developer CTI Molecular Imaging of Knoxville, TN, has hired Greg Brophy as senior vice president and general counsel.
November 5, 2002
P.E.T.Net and UCLA sign molecular imaging pact
By AuntMinnie.com staff writers
Radiopharmaceutical provider P.E.T.Net Pharmaceuticals of Knoxville, TN has signed a licensing agreement with the University of California, Los Angeles, for development rights to molecular imaging probes for the COX-2 enzyme.
November 3, 2002
Wagner sees bright future for molecular imaging
By Robert Bruce
Perhaps no one deserves more credit than Dr. Henry Wagner for the rapid diffusion of the term "molecular imaging" into radiology’s lexicon. In an interview with AuntMinnie.com, Wagner shares his thoughts and opinions on the emerging field.
October 30, 2002
2002 10 30 16 36 17 706
New SNM regulatory guide for nuclear medicine
By AuntMinnie.com staff writers
The Society of Nuclear Medicine (SNM) has published a reference guide for nuclear medicine professionals who want to bring their facilities into compliance with recently revised U.S. regulations governing the medical use of nuclear byproduct materials.
October 29, 2002
Previous Page
Page 399 of 440
Next Page